Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)
32.95
-1.74 (-5.02%)
Nov 20, 2026, 3:04 PM CST
SHE:300573 Revenue
Shenyang Xingqi Pharmaceutical had revenue of 836.74M CNY in the quarter ending September 30, 2026, with 12.92% growth. This brings the company's total for the last twelve months to 2.81B, up 16.57% year-over-year. In the year 2025, Shenyang Xingqi Pharmaceutical had annual revenue of 2.47B with 27.24% growth. That makes Shenyang Xingqi Pharmaceutical the 12,298th largest company in the world by revenue and 2,121st in China.
Revenue (ttm)
2.81B
Revenue Growth
+16.57%
P/S Ratio
4.17
Revenue / Employee
1.17M
Employees
2,396
Market Cap
11.69B
Revenue by Segment
- Pharmaceutical Manufacturing 2.39B 96.5%
- Medical Service 66.10M 2.7%
- Unallocated Other Operations 19.92M 0.8%
Fiscal year ended Dec 31, 2025 See the full SHE:300573 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.47B | 529.46M | 27.24% |
| Dec 31, 2024 | 1.94B | 475.82M | 32.42% |
| Dec 31, 2023 | 1.47B | 217.71M | 17.42% |
| Jan 1, 2023 | 1.25B | 221.94M | 21.59% |
| Jan 1, 2022 | 1.03B | 339.23M | 49.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.